HORIZONROBOT-W (09660) awarded approximately 36.7 million shares of bonus shares.
Horizon Robotics-W (09660) announced that on January 15, 2025, the company has conducted its initial public offering...
HORIZONROBOT-W (09660) announced that on January 15, 2025, the company has granted a total of 36,704,895 shares of Class B ordinary shares to 198 grantees in accordance with the terms of the first public offering of shares incentive plan. The shares can only be exercised after acceptance by the grantees.
Related Articles
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
RECOMMEND
